Get started
Author

Natalia Rompoti

Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: A dermatologist and nail expert group consensus
2019 · Dimitrios Rigopoulos, Robert Baran, et al. · Journal of the American Academy of Dermatology · 144
PDF
Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study
2022 · Tiago Torres, Luis Puig, et al. · American Journal of Clinical Dermatology · 84
Real‐world data on the efficacy and safety of apremilast in patients with moderate‐to‐severe plaque psoriasis
2018 · E. Papadavid, N. Rompoti, et al. · Journal of the European Academy of Dermatology and Venereology · 77
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study
2024 · Tiago Torres, Andrea Chiricozzi, et al. · American Journal of Clinical Dermatology · 76
PDF
Real world data from the use of secukinumab in the treatment of moderate‐to‐severe psoriasis, including scalp and palmoplantar psoriasis: A 104‐week clinical study
2019 · Natalia Rompoti, Pelagia Katsimbri, et al. · Dermatologic Therapy · 50
PDF
The Impact of Treatment with IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients with Plaque Psoriasis and/or Psoriatic Arthritis: A Systematic Review
2023 · Aikaterini Tsiogka, Stamatios Gregoriou, et al. · Biomedicines · 45
PDF
Real‐world data from a single Greek centre on the use of secukinumab in plaque psoriasis: effectiveness, safety, drug survival, and identification of patients that sustain optimal response
2020 · N. Rompoti, P. Sidiropoulou, et al. · Journal of the European Academy of Dermatology and Venereology · 37
Schmerzreduktion bei Patienten mit chronischem Ulcus cruris durch ein neu entwickeltes Morphingel
2011 · L. Huptas, N. Rompoti, et al. · Der Hautarzt · 35
Combination of BRAF Inhibitors and Brain Radiotherapy in Patients With Metastatic Melanoma Shows Minimal Acute Toxicity
2013 · Natalia Rompoti, Bastian Schilling, et al. · Journal of Clinical Oncology · 34
PDF
Brodalumab in plaque psoriasis: Real‐world data on effectiveness, safety and clinical predictive factors of initial response and drug survival over a period of 104 weeks
2022 · Natalia Rompoti, Maria Politou, et al. · Journal of the European Academy of Dermatology and Venereology · 33
Age affects drug survival rates of interleukin ( IL )‐17 and IL ‐23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi‐country, cohort study
2024 · Andrea Chiricozzi, Giulia Coscarella, et al. · Journal of the European Academy of Dermatology and Venereology · 16
Treatment of nail psoriasis with calcipotriol/betamethasone dipropionate foam versus pulse dye laser: an unblinded, intra‐patient, left‐to‐right prospective study
2020 · S. Gregoriou, P. Sidiropoulou, et al. · Journal of the European Academy of Dermatology and Venereology · 15
Management of Nail Psoriasis
2021 · Dimitrios Rigopoulos, Natalia Rompoti, et al. · Dermatologic Clinics · 14
Lymphopenia and CD4+/CD8+ Cell Reduction under Fumaric Acid Esters
2017 · Wiebke Sondermann, Natalia Rompoti, et al. · Dermatology · 13
Real-World Effectiveness and Safety of Dupilumab, Tralokinumab, and Upadacitinib in Patients with Atopic Dermatitis: A 52-Week International, Multicenter Retrospective Cohort Study
2025 · Tiago Torres, Jensen Yeung, et al. · Dermatology and Therapy · 12
PDF
Drug survival of dupilumab, tralokinumab and upadacitinib in patients with atopic dermatitis: An international, real‐world comparative study
2025 · Tiago Torres, Jensen Yeung, et al. · Journal of the European Academy of Dermatology and Venereology · 12
PDF
Photodynamic Therapy for the Treatment of Basal Cell Carcinoma: A Comprehensive Review of Randomized Controlled Trials
2024 · Ioannis-Alexios Koumprentziotis, Natalia Rompoti, et al. · Dermatology Practical & Conceptual · 12
Corticosteroids Augment BRAF Inhibitor Vemurafenib Induced Lymphopenia and Risk of Infection
2015 · Wiebke Sondermann, Klaus G. Griewank, et al. · PLoS ONE · 11
PDF
Psychopathological Profile of Patients with Moderate-to-Severe Plaque Psoriasis and Its Correlation to DLQI: Results from a Prospective, Monocentric Clinical Study
2024 · Natalia Rompoti, Sofia Tsiori, et al. · Journal of Clinical Medicine · 9
PDF
Bimekizumab in psoriasis: a monocentric study evaluating short- and mid-term effectiveness and safety profile in a real-world setting
2024 · Natalia Rompoti, Irene Stefanaki, et al. · Archives of Dermatological Research · 9
Psychopathology and Alexithymia in Patients with Moderate-to-Severe Psoriasis: Development of a Novel Index with Prognostic Value
2022 · Sofia Tsiori, Natalia Rompoti, et al. · International Journal of Environmental Research and Public Health · 9
PDF
Systemic inflammation correlates with depression and lower quality of life in patients with hidradenitis suppurativa independent of disease severity
2025 · Nikolaos Rotsiamis, Natalia Rompoti, et al. · Archives of Dermatological Research · 6
The impact of treatment with IL-17/IL-23 inhibitors on subclinical atherosclerosis in patients with plaque psoriasis and/or psoriatic arthritis: a systematic review
2022 · Aikaterini Tsiogka, Stamatios Gregoriou, et al. · 6
PDF
Switching within the class of IL ‐17 inhibitors for the treatment of plaque psoriasis: A real‐world retrospective study
2024 · Ioannis‐Alexios Koumprentziotis, Natalia Rompoti, et al. · Australasian Journal of Dermatology · 5
PDF
Real‐world effectiveness, drug survival and safety of risankizumab over a period of 2 years in 158 patients with moderate‐to‐severe plaque psoriasis
2024 · Natalia Rompoti, Irene Stefanaki, et al. · Journal of the European Academy of Dermatology and Venereology · 5
PDF
Works count: 53
Citation count: 813
H-index: 13
I10-index: 18
Year
Topic
Type